Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M. J. Gooderham"'
Autor:
D. N. Adam, M. J. Gooderham, J. R. Beecker, C. H. Hong, C. S. Jack, V. Jain, P. Lansang, C. W. Lynde, K. A. Papp, V. H. Prajapati, I. Turchin, J. Yeung
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 37:1135-1148
Autor:
S. Ständer, N. Bhatia, M. J. Gooderham, J. I. Silverberg, J. P. Thyssen, P. Biswas, M. DiBonaventura, W. Romero, S. A. Farooqui
Publikováno v:
Stander, S, Bhatia, N, Gooderham, M J, Silverberg, J, Thyssen, J P, Biswas, P, DiBonaventura, M, Romero, W & Farooqui, S A 2022, ' High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits : pooled analyses of abrocitinib monotherapy studies in adults and adolescents ', Journal of the European Academy of Dermatology and Venereology, vol. 36, no. 8, pp. 1308-1317 . https://doi.org/10.1111/jdv.18170
Once-daily abrocitinib treatment provided meaningful improvements in signs and symptoms of moderate-to-severe atopic dermatitis (AD) in randomized controlled studies.To evaluate proportions of patients with responses meeting higher threshold efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d026512c5f37c6345f908a31063dea49
https://curis.ku.dk/portal/da/publications/high-threshold-efficacy-responses-in-moderatetosevere-atopic-dermatitis-are-associated-with-additional-quality-of-life-benefits(2871bc48-86c0-4ded-bf46-79a96d3e45e7).html
https://curis.ku.dk/portal/da/publications/high-threshold-efficacy-responses-in-moderatetosevere-atopic-dermatitis-are-associated-with-additional-quality-of-life-benefits(2871bc48-86c0-4ded-bf46-79a96d3e45e7).html